NSEAnalysts/Institutional Investor Meet/Con. Call Updates26 Oct 2026 · 26 Oct 2026, 04:40 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Marksans Pharma Limited · MARKSANS
✦ AI SummaryResults
Marksans Pharma Limited has scheduled a conference call on November 05, 2026, to discuss its unaudited financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Marksans Pharma Limited has informed the Exchange about Schedule for Q2FY27 Earnings Conference Call
Attachments (1)
📄pdf
Download →
MARKSANS_26102026164015_Seintimation.pdf
View document text
October 26, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relation Department Listing Department
Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Bandra-Kurla Complex,
Mumbai – 400001. Bandra (East), Mumbai – 400051.
Scrip Code: 524404 Symbol: MARKSANS
Subject: Intimation of schedule for Q2FY27 Earnings Conference Call
Dear Sir/Madam,
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the
Company has scheduled a conference call for analysts and investors on Thursday, November 05,
2026 at 04:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and
Consolidated) of the Company for the quarter and half year ended September 30, 2026.
The details and schedule with respect to the conference call are enclosed herewith.
The presentation along with the audio recording of the call and the transcript will be hosted on
the Company’s website at https://www.marksanspharma.com/earnings-call-transcripts.html
We request you to take the aforesaid on your records.
Thanking you.
Yours faithfully,
For Marksans Pharma Limited
Harshavardhan Panigrahi
Company Secretary
Encl: As below
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri
(W), Mumbai - 400 053 Tel.: +91 22 4001 2000
E-mail: companysecretary@marksanspharma.com
www.marksanspharma.com
SYSTEMATIX INSTITUTIONAL EQUITIES
Invites you to participate in
Q2FY27 Results Conference Call of
Marksans Pharma Limited
On Thursday, 5th November 2026 at 4:00 PM (IST)
The management will be represented by
Mr. Mark Saldanha Mr. Jitendra Sharma
Founder, Chairman, and Managing Director Chief Financial Officer
Dial-in-number
Location Dial Number Location Toll Free Number
USA : 1 866 746 2133
Primary Number +91 22 6280 1297
UK : 0 808 101 1573
Singapore : 800 101 2045
Secondary Number +91 22 7115 8198
Hong Kong : 800 964 448
Click here for your Diamond Pass™
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=4215452&linkSecurityString=254ce79eb0
DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator.
For more information, please contact:
Vishal Manchanda Mrunal Pawar
Equity Research Analyst Senior VP & Group Head - Corporate Access &
Contact No: +91 97374 37148 Corporate Communication
vishalmanchanda@systematixgroup.in Contact No: + 91 22 6704 8088
mrunalpawar@systematixgroup.in